‘Proactive Pharmacovigilance’ Essential to Combating Opioid Epidemic, FDA Says

Drug Industry Daily
Spotting shifting trends in opioid addiction and using a systematic approach to monitoring them is essential to protecting the public from the opioid crisis and intervening against it, top FDA officials said in the New England Journal of Medicine.

To View This Article:


Subscribe To Drug Industry Daily